GEN Exclusives

More »

GEN News Highlights

More »
Feb 2, 2010

Bayer Schering Pharma and BRAIN Team Up to Improve Efficiency of Steroid Synthesis

  • Bayer Schering Pharma and BRAIN are pooling their expertise to develop methods for the energy-efficient and sustainable production of steroid compounds by fermentation.

    The goal is to use optimized designer-bug microbial production strains and plant-derived raw materials. The companies hope the new process could enable the achievement of higher yields using lower energy input and potentially reduce greenhouse gas output by some 10%.

    BRAIN is an industrial biotech company specialized in the discovery and development of natural bioactive compounds and enzymes for partners and customers. The company is leveraging its BioArchive, which reportedly comprises millions of genes, proteins, and metabolic pathways from microbial isolates and metagenome libraries.


Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »